Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
EV/Core EBITDA

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

GENPHARMASEC Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023
   EV/Core EBITDA(x) 32.66153.69244.10

What is the latest EV/Core EBITDA ratio of GENPHARMASEC ?

The latest EV/Core EBITDA ratio of GENPHARMASEC is 32.66 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202532.66
Mar2024153.69
Mar2023244.10

How is EV/Core EBITDA of GENPHARMASEC Trending?

Years EV/Core EBITDA % Change
Mar2025 32.66
-78.75
Mar2024 153.69
-37.04
Mar2023 244.1 -

Other Financial Ratios of GENPHARMASEC


Compare EV/Core EBITDA ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹51.5 Cr -9.7% -29% -55.3% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹6,367.6 Cr 1.1% -11.7% -19.4% Stock Analytics
KIRI INDUSTRIES ₹2,252.4 Cr -1.7% -17.6% -34.6% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,395.2 Cr -3% -12.7% -39.5% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹966.3 Cr 0.8% -14.8% 8.9% Stock Analytics
BODAL CHEMICALS ₹684.9 Cr 25.2% 13.5% -19.4% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-9.7%

-29%

-55.3%

SENSEX

-0%

-10.7%

1%


You may also like the below Video Courses